2nd Quarter - Termination

SPARK THERAPEUTICS, INC. for SPARK THERAPEUTICS, INC.

Firm
Client
Income
—
Expenses
$100,000
Expense method
A: Lobbying Disclosure Act definitions
Terminated
Jun 1, 2025

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R. 1 - One Big Beautiful Bill Act; provisions related to health. H.R. 1968 - Full-Year Continuing Appropriations and Extensions Act, 2025; provisions related to health. S. 1637 - MVP Act; all provisions.

LobbyistCovered position, as disclosed
KATHLEEN M. MCAULIFFE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1637 (119th), H.R. 1968 (119th), H.R. 1 (119th)

Health Issues HCR

H.R. 1262/S. 932 - Give Kids a Chance Act of 2025; all provisions. H.R. 1509/S. 752 - Accelerating Kids Access to Care Act of 2025; all provisions.

LobbyistCovered position, as disclosed
KATHLEEN M. MCAULIFFE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1262 (119th), S. 932 (119th), H.R. 1509 (119th), S. 752 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.